A randomized phase I/II study of everolimus, irinotecan, and cetuximab versus capecitabine and oxaliplatin in gemcitabine-resistant patients with pancreatic cancer.

被引：0
|
作者：
Bjerregaard, Jon Kroll
Ladekarl, Morten
Jensen, Helle Anita
Vestermark, Lene Weber
Farr, Katherina Podlekareva
Pfeiffer, Per
机构：
[1] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark
[2] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark
[3] Odense Univ Hosp, DK-5000 Odense, Denmark
[4] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e15238
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15238
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial
    Se Hyun Kim
    Sang Joon Shin
    Sun Young Kim
    Se Hoon Lee
    Young Suk Park
    Se Hoon Park
    Kyung Hee Lee
    Tae Won Kim
    Yong Sang Hong
    Joong Bae Ahn
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 91 - 97
  • [32] Capecitabine in combination with oxaliplatin or with irinotecan in elderly patients with advanced colorectal cancer: Preliminary results of a randomized phase ii study
    Rosati, G.
    Cordio, S.
    Bordonaro, R.
    Gebbia, V.
    Borsellino, N.
    Giannitto, G.
    Rinaldi, A.
    Reggiardo, G.
    Manzione, L.
    ANNALS OF ONCOLOGY, 2007, 18 : 20 - 20
  • [33] Capecitabine in combination with oxaliplatin or with irinotecan in elderly patients with advanced colorectal cancer: Preliminary results of a randomized phase II study
    Rosati, G.
    Cordio, S.
    Bordonaro, R.
    Gebbia, V
    Rinaldi, A.
    Giannitto, G.
    Borsellino, N.
    Reggiardo, G.
    Manzione, L.
    ANNALS OF ONCOLOGY, 2007, 18 : 189 - 189
  • [34] Capecitabine in combination with oxaliplatin or with irinotecan in elderly patients with advanced colorectal cancer: Preliminary results of a randomized phase II study
    Rosati, G.
    Cordio, S.
    Bordonaro, R.
    Gebbia, V
    Rinalci, A.
    Giannitto, G.
    Borsellino, N.
    Reggiardo, G.
    ANNALS OF ONCOLOGY, 2007, 18 : VII28 - VII29
  • [35] RTOG 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan versus capecitabine and oxaliplatin with concurrent radiation therapy for locally advanced rectal cancer
    Wong, S. J.
    Winter, K.
    Meropol, N. J.
    Anne, R.
    Kachnic, L. A.
    Rashid, A.
    Watson, J. C.
    Mitchell, E. P.
    Pollock, J.
    Lee, R. J.
    Willett, C. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial
    Hess, V.
    Pratsch, S.
    Potthast, S.
    Lee, L.
    Winterhalder, R.
    Widmer, L.
    Cescato, C.
    Lohri, A.
    Jost, L.
    Stillhart, P.
    Pestalozzi, B.
    Herrmann, R.
    ANNALS OF ONCOLOGY, 2010, 21 (12) : 2390 - 2395
  • [37] A randomized phase II clinical trial of gemcitabine, oxaliplatin, erlotinib combination chemotherapy versus gemcitabine and erlotinib in previously untreated patients with locally advanced or metastatic pancreatic cancer.
    Lim, Sung Hee
    Yun, Jina
    Lee, Min-Young
    Kim, Han Jo
    Kim, Kyoung Ha
    Kim, Se Hyung
    Lee, Sang-Cheol
    Bae, Sang Byung
    Kim, Chan Kyu
    Lee, Namsu
    Lee, Kyu Taek
    Park, Sung Kyu
    Hong, Dae Sik
    Choi, Hyun Jong
    Moon, Jong Ho
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [38] A phase I study of oxaliplatin, full-dose gemcitabine and concurrent radiation therapy in patients with pancreatic cancer.
    Desai, S. P.
    Ben-Josef, E.
    Lawrence, T. J.
    Francis, I. R.
    Greenson, J. K.
    Alfred, C. E.
    Colletti, L. M.
    Simeone, D. M.
    Normolle, D. P.
    Zalupski, M. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 204S - 204S
  • [39] Salvage Therapy with Mitomycin and Ifosfamide in Patients with Gemcitabine-Resistant Metastatic Pancreatic Cancer: A Phase II Trial
    Cereda, Stefano
    Reni, Michele
    Rognone, Alessia
    Fugazza, Clara
    Ghidini, Michele
    Ceraulo, Domenica
    Brioschi, Matteo
    Nicoletti, Roberto
    Villa, Eugenio
    CHEMOTHERAPY, 2011, 57 (02) : 156 - 161
  • [40] Phase II study of capecitabine, irinotecan, and celecoxib in advanced colorectal cancer.
    El-Rayes, BF
    Shields, AF
    Vaishampayan, U
    Heilbrun, L
    Bekaii-Saab, T
    Zalupski, MM
    Philip, PA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 310S - 310S
12345